ORGS
ORGENESIS INC by Orgenesis, Inc. (ORGS)
$80
About ORGENESIS INC by Orgenesis, Inc. (ORGS)
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the following segments: Octomera and Therapies. The Octomera segment refers to the point of care services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
Details
Daily high
$0.80
Daily low
$0.80
Price at open
$0.80
52 Week High
$5.89
52 Week Low
$0.00
Market cap
4.1M
Dividend yield
0.00%
Volume
102
Avg. volume
876
P/E ratio
-.09
ORGENESIS INC by Orgenesis, Inc. News
Details
Daily high
$0.80
Daily low
$0.80
Price at open
$0.80
52 Week High
$5.89
52 Week Low
$0.00
Market cap
4.1M
Dividend yield
0.00%
Volume
102
Avg. volume
876
P/E ratio
-.09